Fatty acid uptake activates an AXL-CAV1-β-catenin axis to drive melanoma progression.
Chocarro-Calvo A. et al, (2025), Genes & development, 39, 463 - 489
Single-cell transcriptomic landscape deciphers intratumoral heterogeneity and subtypes of acral and mucosal melanoma.
Li Y. et al, (2025), Clinical cancer research : an official journal of the American Association for Cancer Research
Functional specialization of MITF, TFEB and TFE3 drives radically distinct adaptive gene expression programs in melanoma.
Dias D. et al, (2024), bioRxiv
The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State
Johns E. et al, (2024), Pigment Cell & Melanoma Research
A High-Throughput Drug Repurposing Strategy to Treat TBX2 and/or TBX3 Dependent Cancers.
Bleloch JS. et al, (2024), Cancer medicine, 13
Mi-2β promotes immune evasion in melanoma by activating EZH2 methylation.
Li C. et al, (2024), Nature communications, 15
DNA damage remodels the MITF interactome to increase melanoma genomic instability
Binet R. et al, (2024), Genes & Development, 38, 70 - 94
Single-cell profiling of MC1R-inhibited melanocytes.
Berns HM. et al, (2023), Pigment cell & melanoma research
Acetylation reprograms MITF target selectivity and residence time
Louphrasitthiphol P. et al, (2023), Nature Communications, 14
The integrated stress response effector ATF4 is an obligatory metabolic activator of NRF2.
Kreß JKC. et al, (2023), Cell reports, 42
AMPK phosphorylates ZDHHC13 to increase MC1R activity and suppress melanomagenesis.
Sun Y. et al, (2023), Cancer Res
Sublethal cytochrome c release generates drug-tolerant persister cells.
Kalkavan H. et al, (2022), Cell, 185, 3356 - 3374.e22
The MITF regulatory network in melanoma.
Chauhan JS. et al, (2022), Pigment cell & melanoma research, 35, 517 - 533
Reciprocal Regulation of BRN2 and NOTCH1/2 Signaling Synergistically Drives Melanoma Cell Migration and Invasion.
Fane ME. et al, (2022), The Journal of investigative dermatology, 142, 1845 - 1857
MC1R Functions, Expression, and Implications for Targeted Therapy.
Guida S. et al, (2022), The Journal of investigative dermatology, 142, 293 - 302.e1